VALERIO, ANNA CANDIDA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.801
AS - Asia 1.766
EU - Europa 960
AF - Africa 375
SA - Sud America 340
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 14
Totale 7.287
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.609
SG - Singapore 678
CN - Cina 376
BR - Brasile 202
HK - Hong Kong 202
FI - Finlandia 121
VN - Vietnam 114
SE - Svezia 105
PL - Polonia 96
DE - Germania 87
IT - Italia 73
FR - Francia 65
UA - Ucraina 60
KR - Corea 42
RU - Federazione Russa 37
AR - Argentina 28
TR - Turchia 26
GB - Regno Unito 25
MX - Messico 22
NL - Olanda 22
JP - Giappone 20
IN - India 19
ES - Italia 18
AD - Andorra 17
CO - Colombia 16
EC - Ecuador 16
IL - Israele 16
VE - Venezuela 16
AO - Angola 15
GR - Grecia 15
UY - Uruguay 15
AU - Australia 14
CR - Costa Rica 14
KG - Kirghizistan 14
KZ - Kazakistan 14
MD - Moldavia 14
NO - Norvegia 14
PR - Porto Rico 14
PS - Palestinian Territory 14
BD - Bangladesh 13
GM - Gambi 13
HR - Croazia 13
JO - Giordania 13
MY - Malesia 13
PE - Perù 13
PY - Paraguay 13
SI - Slovenia 13
ZA - Sudafrica 13
CA - Canada 12
CM - Camerun 12
CY - Cipro 12
DJ - Gibuti 12
GT - Guatemala 12
IR - Iran 12
MA - Marocco 12
PA - Panama 12
TZ - Tanzania 12
UG - Uganda 12
BG - Bulgaria 11
BW - Botswana 11
CH - Svizzera 11
CI - Costa d'Avorio 11
GH - Ghana 11
IE - Irlanda 11
JM - Giamaica 11
LC - Santa Lucia 11
ME - Montenegro 11
MR - Mauritania 11
NE - Niger 11
SD - Sudan 11
AL - Albania 10
AZ - Azerbaigian 10
BZ - Belize 10
CG - Congo 10
CL - Cile 10
ET - Etiopia 10
IQ - Iraq 10
MW - Malawi 10
NP - Nepal 10
PH - Filippine 10
PK - Pakistan 10
RW - Ruanda 10
SN - Senegal 10
TW - Taiwan 10
YE - Yemen 10
YT - Mayotte 10
AT - Austria 9
BB - Barbados 9
CD - Congo 9
DO - Repubblica Dominicana 9
EE - Estonia 9
HU - Ungheria 9
ID - Indonesia 9
LU - Lussemburgo 9
MU - Mauritius 9
NG - Nigeria 9
TN - Tunisia 9
ZM - Zambia 9
ZW - Zimbabwe 9
AF - Afghanistan, Repubblica islamica di 8
Totale 6.939
Salva come PNG Salva come JPEG
Città #
Singapore 381
Chandler 378
Fairfield 361
Woodbridge 345
Jacksonville 288
Ashburn 266
Houston 233
Wilmington 216
Hong Kong 190
Ann Arbor 175
Cambridge 138
Seattle 137
Beijing 107
Santa Clara 100
Boardman 88
Princeton 86
Bytom 76
Des Moines 76
Dong Ket 62
Medford 55
Nanjing 51
Helsinki 48
San Diego 39
Guangzhou 31
Roxbury 31
Ho Chi Minh City 28
Los Angeles 28
Gangdong-gu 19
New York 19
Andorra la Vella 17
Buffalo 16
Changsha 16
São Paulo 16
Norwalk 14
Bishkek 13
Hebei 13
Shenyang 13
Amman 12
Athens 12
Jiaxing 12
Lima 12
Montevideo 12
Panama City 12
San José 12
Abidjan 11
Castries 11
Chicago 11
Hefei 11
Kampala 11
Luanda 11
Munich 11
Nanchang 11
Ricengo 11
Accra 10
Chisinau 10
Council Bluffs 10
Dakar 10
Dar es Salaam 10
Kigali 10
Limassol 10
Podgorica 10
Djibouti 9
Dublin 9
Harare 9
Lusaka 9
Mamoudzou 9
Nouakchott 9
San Juan 9
Tel Aviv 9
Addis Ababa 8
Baku 8
Bamako 8
Bridgetown 8
Cuauhtémoc 8
Khartoum 8
Kinshasa 8
Niamey 8
Tokyo 8
Vienna 8
Banjul 7
Bologna 7
Cotonou 7
Dallas 7
Gaborone 7
Johannesburg 7
Lilongwe 7
London 7
Maputo 7
Noumea 7
Phnom Penh 7
Pristina 7
Tallinn 7
Tianjin 7
Warsaw 7
Almaty 6
Ankara 6
Antananarivo 6
Brazzaville 6
Douala 6
Guatemala City 6
Totale 4.726
Salva come PNG Salva come JPEG
Nome #
Pancreatic cancer-associated diabetes mellitus: an open field for proteomic applications 178
A rapid method to determine plasma homocysteine concentration and enrichment by gas chromatography/mass spectrometry. 173
Different apoprotein(a) isoform proportions in serum and carotid plaque 158
Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptides 158
Alcohol intake impairs glucose counterregulation during acute insulin-induced hypoglycemia in IDDM patients. Evidence for a critical role of free fatty acids 158
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 158
A 2026 D peptide as the putative pancreatic cancer-associated diabetogenic factor 156
Effects of insulin on methionine and homocysteine kinetics in type 2 diabetes with nephropathy 154
Insulin on methionine and homocysteine kinetics in healthy humans: plasma vs. intracellular models 154
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 148
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 148
Hypoglycemic syndrome in a patient with proinsulin-only secreting pancreatic adenoma (proinsulinoma). 144
Ketone bodies increase glomerular filtration rate in normal man and in patients with Type 1 (insulin-dependent) diabetes mellitus 141
Glucose metabolic alterations in isolated and perfused rat hepatocytes induced by pancreatic cancer conditioned medium: A low molecular weight factor possibly involved 139
Effects of different plasma glucose concentrations on lipolytic and ketogenic responsiveness to epinephrine in type I (insulin-dependent) diabetic subjects 138
Ethanol impairs insulin-mediated glucose uptake by an indirect mechanism 135
Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes 131
Type I insulin-dependent diabetic patients show an impaired renal hemodynamic response to protein intake. 129
The effects of different plasma insulin concentrations on lipolytic and ketogenic responses to epinephrine in normal and Type 1 (insulin-dependent) diabetic humans 129
Impaired renal response to a meat meal in insulin-dependent diabetes: role of glucagon and prostaglandins. 127
Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance. 127
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]i) ,oscillations and insulin release. 123
The haemodinamic abnormalities in short-term insulin deficiency. The role of prostaglandin inhibition. 122
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 119
Pancreatic cancer associated diabetogeni peptide induces nitric oxide synthesis in rat hepathocytes 118
Alcohol impairs insulin sensitivity in normal subjects. 117
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]) oscillations and insulin release. 117
Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblast: searching for a gene expression pattern with a microarray analysis of 5000 skeletal muscle gene 114
Ketone body metabolism in NIDDM. Effect of sulfonylurea treatment 112
The hot but not the cold minimal model allows precise assessment of insulin sensitivity in NIDDM subjects. 112
The pancreatic cancer derived S100A8 N-terminal peptide augments intracellular Ca2+ oscillations and insulin release. 110
Expression profile of pancreatic cancer cell conditioned myoblast: a 5000 muscle genes microarray analysis 103
Pancreatic cancer induced diabetes mellitus: relevance of the S100A8 N-terminal peptide (Nt-S100A8). 101
The pancreatic cancer derived N-terminal peptide of S100A8 stimulates insulin exocytosis and HEPG2 cell growth. 99
Plasma and red cell sorbitol assay in diabetic subjects. 97
Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients 96
Insulin sensitivity and secretion in young,healthy subjects are not changed by Zone and Mediterranean diets. 96
Tecniche di Biochimica Clinica 94
Profilo di espressione di mioblasti condizionati da cellule di cancro del pancreas: analisi mediante microarray di 5000 geni muscolari 93
Isolation and characterization of pancreatic cancer diabetogenic factor: A 14 aminoacids peptide corresponding to the n-terminal sequence of an s-100 calcium binding protein 93
Isolation and characterization of pancreatic cancer (PC) diabetogenic factor: a 14 aminoacids peptide corresponding to the N-terminal sequence of an S-100 calcium binding protein 91
Characterization of pancreatic cancer (PC) diabetogenic factor: a 14 aminoacids peptide corresponding to the N-terminal sequence of an S-100 calcium binding protein 89
Expression profile of pancreatic cncer cells conditioned myoblasts: a 5000 muscle genes microarray analysis 88
Pancreatic cancer pulls down lymphocyte migration 86
Effect of ethanol, acetaldeyde and acetate on inslin and glucagone secretion in the perfused rat pancreas 86
Pancreatic cancer associated diebetogenic factor:a low molecular weight peptide possibly involved. 85
Improvement of basal hepatic glucose production and fasting hyperglycemia of type I diabetic patients treated with human recombinant ultralente insulin 83
Pancreatic cancer (PC) pulls down lymphocyte migration 83
Induction of nitric oxide synthesis in rat hepatocytes by pancreatic cancer associated diabetogenic peptide 79
Diabete associato a carcinoma pancreatico: ruolo di un fattore di 2026 D 78
Pancreatic cancer-associated diabetes is correlated with increased liver nitric oxide (NO) 73
The pancreatic cancer derived N-terminal peptide of S100A8 inhibits insulin exocytosis and stimulates cancer cell growth. 73
The pancreatic cancer derived N-terminal peptide of S100A8 stimulates insulin exocytosis and HEPG2 cell growth. 72
Is red cell sorbitol content a good marker of glycemic control in diabetic patients? 72
The pancreatic cancer derived N-terminal peptide of S100A8 stimulates insulin exocytosis and HEPG2 cell growth. 71
Isolation and characterization of pancreatic cancer (PC) diabetogenic factor: a 14 aminoacids peptide corresponding to the N-terminal sequence of an S-100 calcium binding protein 71
Intracellular lactate and pyruvate-interconversion rates are increased in muscle tissue of non-insulin-depedent diabetic individuals 71
Un peptide diabetogeno carcinoma pancreatico-associato induce la sintesi di ossido nitrico negli epatociti di ratto 69
Un aumento dell`ossido nitrico (NO) epatico caratterizza il diabete carcinoma pancreatico-associato 69
Quaderni di Biochimica Clinica 69
Pancreatic cancer associated diabetogenic peptide induces nitric oxide synthesis in rat hepatocytes 68
Diabete associato a carcinoma pancreatico: ruolo di un fattore di 2026 D 67
Identification of pro- and anti-diabetogenic peptide(s) in portal sera of patients with pancreatic cancer 66
The pancreatic cancer derived N-terminal peptide of S100A8 inhibits insulin exocytosis and stimulates cancer cell growth. 64
Pancreatic cancer-associated diabetes is correlated with increased liver nitric oxide (NO) 63
Glycosilated serum proteins in diabetic patients and their relation to metabolic parameters. 62
Pancreatic cancer associated diabetogenic peptide induces nitric oxide synthesis in rat hepatocytes 60
Pancreatic cancer associated diabetogenic peptide induces nitric oxide synthesis in rat hepatocytes 58
Identificazione di uno o piu` peptidi pro- e anti-diabetogenici nel siero portale di pazienti affetti da cancro del pancreas 56
Pancreatic cancer-associated diabetes is correlated with increased liver nitric oxide (NO) 52
Totale 7.293
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.008
article - articoli 11.078
book - libri 494
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.580
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021399 0 0 0 0 41 41 10 53 70 43 58 83
2021/2022641 4 119 29 62 26 55 18 59 28 8 67 166
2022/2023746 133 102 12 80 114 124 2 54 81 8 22 14
2023/2024360 13 46 36 26 32 45 26 24 9 24 41 38
2024/20251.320 1 83 86 64 200 26 48 68 117 45 266 316
2025/20261.990 171 414 626 585 194 0 0 0 0 0 0 0
Totale 7.293